A PHASE 2b/3 RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL FOR TREATMENT OF PRIMARY BILIARY CHOLANGITIS (PBC) WITH SETANAXIB: OBJECTIVES AND STUDY DESIGN

被引：0
|
作者：
Jones, David [1 ]
Carlsson, Stefan [2 ]
Von Reedtz, Sari [2 ]
Levy, Cynthia [3 ]
机构：
[1] Newcastle Univ, Newcastle Upon Tyne Hosp, Dept Hepatol & Liver Transplantat, Newcastle Upon Tyne, Tyne & Wear, England
[2] Calliditas Therapeut AB, Stockholm, Sweden
[3] Univ Miami, Schiff Ctr Liver Dis, Coral Gables, FL 33124 USA
来源：
HEPATOLOGY | 2022年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
4700
引用
收藏
页码：S1461 / S1462
页数：2
相关论文
共 50 条
  • [1] Fenofibrate in primary sclerosing cholangitis; a randomized, double-blind, placebo-controlled trial
    Hatami, Behzad
    Mosala, Mozhde
    Hassani, Amir Hossein
    Ardakani, Mohammad Javad Ehsani
    Gholami, Samira
    Zali, Mohammad Reza
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2022, 10 (04):
  • [2] A phase 2b randomized, double-blind, placebo-controlled trial of ubrogepant for acute treatment of a migraine attack
    Lipton, R. B.
    Voss, T.
    Dodick, D. W.
    Dupre, N.
    Ge, J.
    Bachman, R.
    Assaid, C.
    Aurora, S. K.
    Michelson, D.
    HEADACHE, 2016, 56 : 7 - 7
  • [3] A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy
    Lafayette, Richard
    Barbour, Sean
    Israni, Rubeen
    Wei, Xuelian
    Eren, Necmi
    Floege, Juergen
    Jha, Vivekanand
    Kim, Sung Gyun
    Maes, Bart
    Phoon, Richard K. S.
    Singh, Harmeet
    Tesar, Vladimir
    Lin, Celia J. F.
    Barratt, Jonathan
    KIDNEY INTERNATIONAL, 2024, 105 (06) : 1306 - 1315
  • [4] DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF PREDNISOLONE TREATMENT IN PRIMARY BILIARY-CIRRHOSIS (PBC) - A 3 YEAR UPDATE
    MITCHISON, HC
    BASSENDINE, MF
    WATSON, AJ
    RECORD, CO
    JAMES, OFW
    JOURNAL OF HEPATOLOGY, 1989, 9 (01) : P4 - P4
  • [5] Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial
    Ratziu, V.
    de Guevara, L.
    Safadi, R.
    Poordad, F.
    Fuster, F.
    Flores-Figueroa, J.
    Arrese, M.
    Fracanzani, Anna L.
    Ben Bashat, D.
    Lackner, K.
    Gorfine, T.
    Kadosh, S.
    Oren, R.
    Halperin, M.
    Hayardeny, L.
    Loomba, R.
    Friedman, S.
    Sanyal, Arun J.
    NATURE MEDICINE, 2021, 27 (10) : 1825 - +
  • [6] Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial
    V. Ratziu
    L. de Guevara
    R. Safadi
    F. Poordad
    F. Fuster
    J. Flores-Figueroa
    M. Arrese
    Anna L. Fracanzani
    D. Ben Bashat
    K. Lackner
    T. Gorfine
    S. Kadosh
    R. Oren
    M. Halperin
    L. Hayardeny
    R. Loomba
    S. Friedman
    Arun J. Sanyal
    Nature Medicine, 2021, 27 : 1825 - 1835
  • [7] A double-blind, placebo-controlled, randomized study of infliximab in primary sclerosing cholangitis
    Hommes, Daan W.
    Erkelens, Willernien
    Ponsioen, Cyriel
    Stokkers, Pieter
    Raws, Erik
    van der Spek, Miram
    Ten Kate, Fiebo
    van Deventer, Sander J.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2008, 42 (05) : 522 - 526
  • [8] THE AESOP TRIAL: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY OF OBETICHOLIC ACID IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS
    Larusso, N. F.
    Bowlus, C. L.
    Levy, C.
    Vuppalanchi, R.
    Floreani, A.
    Andreone, P.
    Srestha, R.
    Trotter, J.
    Goldberg, D.
    Rushbrook, S.
    Hirschfield, G. M.
    Van Biene, C.
    Penceck, R.
    Macconell, L.
    David, S.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : E67 - E67
  • [9] The AESOP Trial: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Obeticholic Acid in Patients with Primary Sclerosing Cholangitis
    Kowdley, Kris V.
    Bowlus, Christopher L.
    Levy, Cynthia
    Vuppalanchi, Raj
    Floreani, Annarosa
    Andreone, Pietro
    LaRusso, Nicholas F.
    Shrestha, Roshan
    Trotter, James
    Goldberg, David S.
    Rushbrook, Simon
    Hirschfield, Gideon M.
    Van Biene, Courtney
    Pencek, Richard
    MacConell, Leigh
    Shapiro, David
    HEPATOLOGY, 2017, 66 (06) : 1254A - 1255A
  • [10] EFFICACY AND SAFETY OF ELAFIBRANOR IN PRIMARY BILIARY CHOLANGITIS: RESULTS FROM THE ELATIVE T DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIAL
    Bowlus, Christopher L.
    Kowdley, Kris V.
    Levy, Cynthia
    Akarca, Ulus
    Alvares-Da-Silva, Mario Reis
    Andreone, Pietro
    Arrese, Marco
    Corpechot, Christophe
    Francque, Sven
    Heneghan, Michael A.
    Invernizzi, Pietro
    Jones, David
    Kruger, Frederik C.
    Lawitz, Eric
    Mayo, Marlyn J.
    Shiffman, Mitchell L.
    Swain, Mark G.
    Valera, Jose Miguel
    Vargas, Victor
    Vierling, John M.
    Villamil, Alejandra
    Addy, Carol
    Dietrich, Julie
    Germain, Jean-Michel
    Mazain, Sarah
    Rafailovic, Dragutin
    Tadde, Bachirou
    Miller, Benjamin
    Shu, Jianfen
    Zein, Claudia O.
    Schattenberg, Joern M.
    HEPATOLOGY, 2024, 79 (02) : E40 - E42
12345